Correlation Between Sartorius Stedim and Arkema SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Arkema SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Arkema SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Arkema SA, you can compare the effects of market volatilities on Sartorius Stedim and Arkema SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Arkema SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Arkema SA.

Diversification Opportunities for Sartorius Stedim and Arkema SA

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sartorius and Arkema is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Arkema SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arkema SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Arkema SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arkema SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Arkema SA go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Arkema SA

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 1.84 times more return on investment than Arkema SA. However, Sartorius Stedim is 1.84 times more volatile than Arkema SA. It trades about 0.0 of its potential returns per unit of risk. Arkema SA is currently generating about -0.03 per unit of risk. If you would invest  20,256  in Sartorius Stedim Biotech on September 2, 2024 and sell it today you would lose (2,221) from holding Sartorius Stedim Biotech or give up 10.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Arkema SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Arkema SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arkema SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Sartorius Stedim and Arkema SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Arkema SA

The main advantage of trading using opposite Sartorius Stedim and Arkema SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Arkema SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arkema SA will offset losses from the drop in Arkema SA's long position.
The idea behind Sartorius Stedim Biotech and Arkema SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance